Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  SHENZHEN STOCK EXCHANGE  >  BGI Genomics Co., Ltd.    300676   CNE100003449

BGI GENOMICS CO., LTD.

(300676)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

BGI Genomics : WHO says it is in talks with China's BGI on test kit after Swedish complaint

08/27/2020 | 08:15am EST

The World Health Organization said on Thursday it was looking into whether "observed irregularities" in a COVID-19 PCR swab test made by China's BGI Biotechnology (Wuhan) Co, Ltd were linked to how it was used in Sweden.

The WHO said it had asked the maker for a "root cause analysis".

China's BGI Genomics said on Wednesday its diagnostic coronavirus testing kit has "relatively high accuracy", a day after Sweden said about 3,700 people received false positive results due to a fault in the company's product.

The WHO, which has approved the tests for emergency use, said in reply to a Reuters query: "WHO was notified and has activated the complaint procedure for in vitro diagnostics ... to gauge if the observed irregularities were due to the way the test was used.  

  "Specifically, WHO has contacted the manufacturer and requested a root cause analysis... We are continuing the work with BGI to determine if further action is required," it said.

(Reporting by Stephanie Nebehay in Geneva, Roxanne Liu in Beijing and Miyoung Kim in Seoul; writing by Stephanie Nebehay; ; editing by John Stonestreet)


© Reuters 2020
All news about BGI GENOMICS CO., LTD.
09/23China's BGI wins 1.5 million coronavirus test kit order from Ethiopia
RE
09/23China's BGI wins 1.5 mln coronavirus test kit order from Ethiopia
RE
08/27BGI GENOMICS : WHO says it is in talks with China's BGI on test kit after Swedis..
RE
08/26BGI GENOMICS : China's BGI defends COVID-19 test kit after Swedish criticism
RE
08/24BGI GENOMICS CO., LTD. : half-yearly earnings release
08/05SPECIAL REPORT : COVID opens new doors for China's gene giant
RE
07/22BGI GENOMICS : Chinese genetics company BGI denies U.S. human rights accusations
RE
07/21U.S. adds 11 firms to economic blacklist over China's treatment of Uighurs
RE
07/20U.S. adds 11 firms to economic blacklist over China's treatment of Uighurs
RE
07/14BGI GENOMICS : China's BGI forecasts 700% jump in first-half profit due to COVID..
RE
More news
Financials
Sales 2020 8 985 M 1 366 M 1 366 M
Net income 2020 3 530 M 537 M 537 M
Net Debt 2020 - - -
P/E ratio 2020 14,7x
Yield 2020 0,15%
Capitalization 51 346 M 7 809 M 7 808 M
Capi. / Sales 2020 5,71x
Capi. / Sales 2021 9,58x
Nbr of Employees -
Free-Float 100,0%
Chart BGI GENOMICS CO., LTD.
Duration : Period :
BGI Genomics Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BGI GENOMICS CO., LTD.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Average target price
Last Close Price 129,63 
Spread / Highest target -
Spread / Average Target -
Spread / Lowest Target -
EPS Revisions
Managers
NameTitle
Ye Yin General Manager & Director
Jian Wang Chairman
Song Gang Li Chairman-Supervisory Board
Yi Qing Chen Chief Financial Officer
Jun Wang Director
Sector and Competitors
1st jan.Capitalization (M$)
BGI GENOMICS CO., LTD.88.69%7 770
EXACT SCIENCES CORPORATION26.80%18 648
GUARDANT HEALTH, INC.44.61%11 297
INVITAE CORPORATION189.21%8 243
ADAPTIVE BIOTECHNOLOGIES CORPORATION50.43%6 156
IOVANCE BIOTHERAPEUTICS, INC.34.25%5 451